Mechanisms for Organ Dysfunction in Covid-19
Launched by UPPSALA UNIVERSITY · Mar 18, 2020
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Mechanisms for Organ Dysfunction in Covid-19," is focused on understanding how COVID-19 affects different organs in the body, especially in patients who are in intensive care. Researchers at Uppsala University Hospital are looking to find out more about the signs (called biomarkers) that indicate organ problems in people who have suspected or confirmed COVID-19.
To participate in this study, patients need to be admitted to the intensive care unit and have suspected or confirmed COVID-19. The trial is open to individuals aged 65 and older, and it is important to note that pregnant or breastfeeding women, as well as younger individuals, cannot participate. Those who join the trial can expect to undergo various assessments to help researchers learn more about the impact of COVID-19 on organ function. This study is currently recruiting participants, and your involvement could help improve understanding and treatment for future COVID-19 patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted to intensive care
- • suspected or verified COVID-19
- Exclusion Criteria:
- • Pregnancy or breastfeeding
- • Under-age
About Uppsala University
Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Uppsala, , Sweden
Patients applied
Trial Officials
Robert Frithiof, MD. PhD
Principal Investigator
Uppsala University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials